Total Payments
$16,249
2024 Payments
$1,757
Companies
53
Transactions
937
Medicare Patients
9,543
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$15,971 (98.3%)
Education$218.68 (1.3%)
Other$31.99 (0.2%)
Gifts$27.78 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,971 | 926 | 98.3% |
| Education | $218.68 | 7 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31.99 | 3 | 0.2% |
| Gift | $27.78 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,602 | 213 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,938 | 101 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,385 | 68 | $0 (2023) |
| Philips Electronics North America Corporation | $1,363 | 62 | $0 (2023) |
| GENZYME CORPORATION | $834.37 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $817.84 | 47 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $810.93 | 47 | $0 (2024) |
| Mylan Specialty L.P. | $595.94 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $567.70 | 38 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $533.20 | 32 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,757 | 100 | GlaxoSmithKline, LLC. ($489.50) |
| 2023 | $1,750 | 104 | GlaxoSmithKline, LLC. ($491.93) |
| 2022 | $3,027 | 158 | GlaxoSmithKline, LLC. ($432.84) |
| 2021 | $2,010 | 117 | Actelion Pharmaceuticals US, Inc. ($336.28) |
| 2020 | $1,558 | 86 | Actelion Pharmaceuticals US, Inc. ($370.90) |
| 2019 | $2,064 | 127 | Philips Electronics North America Corporation ($302.48) |
| 2018 | $1,979 | 126 | GlaxoSmithKline, LLC. ($259.58) |
| 2017 | $2,104 | 119 | Respiratory Technologies, Inc. ($500.73) |
All Payment Transactions
937 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $27.63 | General |
| Category: HFCWO | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Airway Clearance Device | ||||||
| 10/25/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: HFCWO | ||||||
| 10/25/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.93 | General |
| Category: HFCWO | ||||||
| 10/25/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $8.90 | General |
| Category: HFCWO | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $22.09 | General |
| Category: Medical Device | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.52 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,590 | 4,010 | $789,753 | $312,688 |
| 2022 | 21 | 2,659 | 4,112 | $751,006 | $288,254 |
| 2021 | 15 | 2,264 | 4,036 | $792,557 | $311,737 |
| 2020 | 24 | 2,030 | 3,646 | $726,271 | $279,912 |
Total Patients
9,543
Total Services
15,804
Medicare Billing
$1.2M
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 490 | 1,169 | $151,970 | $74,159 | 48.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 392 | 705 | $153,705 | $66,999 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 373 | 585 | $111,150 | $54,692 | 49.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 265 | 346 | $55,360 | $22,591 | 40.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 109 | 111 | $45,251 | $15,436 | 34.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 108 | 110 | $30,250 | $11,450 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $23,320 | $10,484 | 45.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 40 | 48 | $38,457 | $8,355 | 21.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 17 | 17 | $27,880 | $8,342 | 29.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 164 | 168 | $25,200 | $7,283 | 28.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 164 | 168 | $35,280 | $6,890 | 19.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 15 | 15 | $22,350 | $6,753 | 30.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 21 | 100 | $12,000 | $5,942 | 49.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 177 | 181 | $17,195 | $3,631 | 21.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 36 | 48 | $4,800 | $1,938 | 40.4% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 19 | 21 | $10,215 | $1,850 | 18.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 12 | 21 | $3,360 | $1,782 | 53.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 47 | 54 | $5,130 | $1,261 | 24.6% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 14 | 14 | $6,300 | $957.50 | 15.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 13 | $1,820 | $859.44 | 47.2% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 11 | 12 | $6,840 | $662.30 | 9.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 15 | 16 | $1,920 | $372.68 | 19.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 324 | 740 | $152,532 | $59,772 | 39.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 421 | 1,014 | $132,075 | $56,825 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 368 | 570 | $108,300 | $53,805 | 49.7% |
About Dr. Eugene Go, MD
Dr. Eugene Go, MD is a Internal Medicine healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730166125.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Go, MD has received a total of $16,249 in payments from pharmaceutical and medical device companies, with $1,757 received in 2024. These payments were reported across 937 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($15,971).
As a Medicare-enrolled provider, Go has provided services to 9,543 Medicare beneficiaries, totaling 15,804 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Orlando, FL
- Active Since 12/27/2005
- Last Updated 12/01/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730166125
Products in Payments
- DUPIXENT (Biological) $1,578
- TRELEGY ELLIPTA (Drug) $1,182
- NUCALA (Biological) $1,079
- UPTRAVI (Drug) $940.80
- (8874) inCourage (Device) $744.48
- FASENRA (Biological) $618.75
- Yupelri (Drug) $426.94
- XOLAIR (Biological) $422.11
- Adempas (Drug) $395.80
- BREZTRI (Drug) $370.62
- OPSUMIT (Drug) $331.72
- OFEV (Drug) $325.81
- SMARTVEST (Device) $309.78
- ORENITRAM (Drug) $293.00
- BEVESPI AEROSPHERE (Drug) $288.48
- inCourage (Device) $269.09
- LONHALA MAGNAIR (Drug) $265.72
- Wakix (Drug) $254.16
- GLASSIA (Biological) $232.04
- ANORO (Drug) $200.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Orlando
Dr. Shahram Mori, Md, MD
Internal Medicine — Payments: $983,741
Internal Medicine $983,741
Michel Velez, Md, MD
Internal Medicine — Payments: $837,815
Internal Medicine $837,815
Dr. Rushang Patel, M.d, Ph.d, M.D, PH.D
Internal Medicine — Payments: $347,712
Internal Medicine $347,712
Dr. Jason Korenblit, M.d, M.D
Internal Medicine — Payments: $294,920
Internal Medicine $294,920
Kwabena Ayesu, Md, MD
Internal Medicine — Payments: $265,751
Internal Medicine $265,751
Dennis Yang, Md, MD
Internal Medicine — Payments: $203,483
Internal Medicine $203,483